Loading clinical trials...
Loading clinical trials...
This study investigated the acute effects of ingesting 400 mg of caffeine administered 30 minutes before Brazilian jiu-jitsu-specific strength endurance tests. Experienced athletes completed two conditions, placebo and caffeine, in a randomized, double-blind, crossover clinical trial. Performance was assessed using the dynamic component of the kimono grip strength test (maximum number of repetitions, MNR) and the isometric component (maximum static lift, MSL), both performed with a gi grip. Rating of perceived exertion, adverse effects, and blinding effectiveness were also evaluated.
Caffeine is a widely used ergogenic aid in combat sports due to its effects on alertness, strength, and muscular endurance. This study evaluated whether an absolute dose of 400 mg of caffeine, ingested 30 minutes before testing, improved performance in Brazilian jiu-jitsu-specific strength endurance tests performed with a gi grip. Fifteen experienced athletes completed two experimental sessions separated by at least seven days in a randomized, double-blind, crossover design. In each session, participants performed three maximal sets of the dynamic component of the kimono grip strength test (maximum number of repetitions, MNR) and three trials of the isometric component (maximum static lift, MSL). Dietary intake was controlled during the 24 hours preceding each session, and athletes were instructed to avoid stimulant substances. Adverse effects were monitored for 24 hours following each session, and blinding effectiveness was assessed using the Bang blinding index. The study also examined interindividual variability in response to caffeine supplementation.
Age
18 - 35 years
Sex
MALE
Healthy Volunteers
Yes
Universidade Federal de Minas Gerais (UFMG), Laboratory of Nutrition and Exercise Training (LAN-UFMG), Belo Horizonte, MG, Brazil
Belo Horizonte, Minas Gerais, Brazil
Start Date
December 12, 2025
Primary Completion Date
January 15, 2026
Completion Date
January 15, 2026
Last Updated
March 18, 2026
15
ACTUAL participants
Caffeine
DIETARY_SUPPLEMENT
Placebo
OTHER
Lead Sponsor
Federal University of Minas Gerais
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07472244